WebDr. Hangfei Tu chose Prof. Marcos García Suero group at ICIQ to develop cutting-edge research while improving other capabilities through specific training… WebThe present invention relates to co-crystals of duloxetine and co-crystal formers selected from COX-INHIBITORs, processes for preparation of the same and their uses as medicaments or in...
Crysforma’s new service: Study of hydrates with our new ... - ICIQ
WebCRYSFORMA, a unit from the Institute of Chemical Research of Catalonia (ICIQ) managed by Dr. Jordi Cerón, provides complete scientific support to the pharmaceutical and fine chemistry industry in the field of pharmaceutical solid state development. CRYSFORMA is currently applying its expertise to use the ALBA synchrotron facilities in its projects in the … WebPostdoctoral Researcher (Postdoc 2024-08 EP/CSOL) - ICIQ bistrot pierre leamington spa england
Jordi Cerón Bertran on LinkedIn: CRYSFORMA, your partner in …
WebMar 30, 2024 · The €544 million funding puts our 218 research leaders, together with their teams of postdoctoral fellows, PhD students and research staff, in pole position to push back the boundaries of our knowledge, break new ground and build foundations for future growth and prosperity in Europe,” commented the European Commissioner for Innovation, … WebCrysforma provides complete scientific support for the discovery, analysis and scale-up of polymorphs, hydrates, amorphous phases, salts and co-crystals of active pharmaceutical ingredients or intermediates. Crysforma has developed its own crystallization screening methodology based on the combination of several crystallization procedures. WebCrysforma has developed its own crystallization screening methodology based in the use of several crystallization procedures, oriented to obtain the thermodynamically stable phase … bistrot photo